Impact of reduced tigecycline susceptibility on clinical outcomes of Acinetobacter bacteremia

被引:3
作者
Chang, Yea-Yuan [1 ,2 ,3 ]
Liu, Yuag-Meng [4 ]
Liu, Chang-Pan [5 ]
Kuo, Shu-Chen [3 ,6 ]
Chen, Te-Li [3 ,7 ]
机构
[1] Natl Yang Ming Univ Hosp, Dept Med, Div Infect Dis, Yilan, Taiwan
[2] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan
[4] Changhua Christian Hosp, Dept Internal Med, Div Infect Dis, Changhua, Taiwan
[5] MacKay Mem Hosp, Dept Internal Med, Div Infect Dis, Taipei, Taiwan
[6] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, 35 Keyan Rd, Zhunan Town 350, Miaoli County, Taiwan
[7] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan
关键词
Tigecycline; Acinetobacter bacteremia; Minimum inhibitory concentration; Appropriate antibiotics; PROGRAM;
D O I
10.1016/j.jmii.2017.08.024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The higher 14-day mortality rate for patients with Acinetobacter bacteremia receiving tigecycline appropriately compared to other appropriate antibiotics (36.4% versus 14.2%, P = 0.028) was due to the poor effect of tigecycline for isolates with a minimum inhibitory concentration of 2 mg/mL (63.6% of 11 versus 14.2% of 127, P = 0.001). Copyright (C) 2017, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
引用
收藏
页码:148 / 152
页数:5
相关论文
共 50 条
  • [31] Clinical Outcomes and Safety of Meropenem-Colistin versus Meropenem-Tigecycline in Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia
    Park, Jae-Min
    Yang, Kyung-Sook
    Chung, You-Seung
    Lee, Ki-Byung
    Kim, Jeong-Yeon
    Kim, Sun-Bean
    Sohn, Jang-Wook
    Yoon, Young-Kyung
    ANTIBIOTICS-BASEL, 2021, 10 (08):
  • [32] Evaluation of the variability in the susceptibility of Acinetobacter baumannii to tigecycline in the same medium with two methods of quantitative diffusion different commercial
    Tejero, Rocio
    Causse, Manuel
    Araceli Moreno, Ma
    Solis, Francisco
    Rodriguez-Lopez, Fernando
    Casal, Manuel
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2012, 25 (03) : 189 - 193
  • [33] Synergistic Activity of Indolicidin and Tigecycline Against Multidrug-Resistant Acinetobacter Baumannii Clinical Isolates
    Altameemi, Rami
    Ghareeb, Abdulameer M.
    Rahal, Basim Shamkhi
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2025, 59 (01) : 92 - 99
  • [34] Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy
    Lee, Yi-Tzu
    Wang, Yung-Chih
    Kuo, Shu-Chen
    Chen, Chung-Ting
    Liu, Chang-Pan
    Liu, Yuag-Meng
    Chen, Te-Li
    Yang, Ya-Sung
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (09)
  • [35] The role of RND efflux pump and global regulators in tigecycline resistance in clinical Acinetobacter baumannii isolates
    Li, Henan
    Wang, Xiaojuan
    Zhang, Yawei
    Zhao, Chunjiang
    Chen, Hongbin
    Jiang, Sen
    Zhang, Feifei
    Wang, Hui
    FUTURE MICROBIOLOGY, 2015, 10 (03) : 337 - 346
  • [36] Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy
    Guner, R.
    Hasanoglu, I.
    Keske, S.
    Kalem, A. K.
    Tasyaran, M. A.
    INFECTION, 2011, 39 (06) : 515 - 518
  • [37] A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects
    Candel, F. J.
    Calvo, N.
    Head, J.
    Sanchez, A.
    Matesanz, M.
    Culebras, E.
    Barrientos, A.
    Picazo, J.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2010, 23 (02) : 103 - 108
  • [38] Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: Role of the global regulator RamA and its local repressor RamR
    Wang, Xiaojuan
    Chen, Hongbin
    Zhang, Yawei
    Wang, Qi
    Zhao, Chunjiang
    Li, Henan
    He, Wenqiang
    Zhang, Feifei
    Wang, Zhanwei
    Li, Shuguang
    Wang, Hui
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 (06) : 635 - 640
  • [39] Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy
    R. Guner
    I. Hasanoglu
    S. Keske
    A. K. Kalem
    M. A. Tasyaran
    Infection, 2011, 39 : 515 - 518
  • [40] Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia
    Dizbay, M.
    Altuncekic, A.
    Sezer, B. Ergut
    Ozdemir, K.
    Arman, D.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 (01) : 29 - 32